Reducing Cardiovascular Risks of Nonsteroidal Anti-Inflammatory Drugs by Using Topical Formulations

American Journal of Cardiology

Volumn 104, Issue 9, 2009, Pages 1315-

  Barkin, Robert L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN; WARFARIN;

BLOOD PRESSURE; CARDIOVASCULAR RISK; CLINICAL PRACTICE; CREATININE CLEARANCE; DRUG BLOOD LEVEL; DRUG DOSAGE FORM COMPARISON; DRUG DOSE COMPARISON; DRUG EXPOSURE; DRUG FORMULATION; DRUG MONITORING; HUMAN; HYPERTENSION; INTERNATIONAL NORMALIZED RATIO; KIDNEY FUNCTION; KNEE OSTEOARTHRITIS; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK REDUCTION; THROMBOSIS;

ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARDIOVASCULAR DISEASES; CREATININE; HUMANS;

EID: 71949105994     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.08.002     Document Type: Letter

References (4)

1. Farkouh M.E., and Greenberg B.P. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am J Cardiol 103 (2009) 1227-1237
2. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., Bierma-Zeinstra S., Brandt K.D., Croft P., Doherty M., Dougados M., Hochberg M., Hunter D.J., Kwoh K., Lohmander L.S., and Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 16 (2008) 137-162
3. Zhang W., Doherty M., Leeb B.F., Alekseeva L., Arden N.K., Bijlsma J.W., Dinçer F., Dziedzic K., Häuselmann H.J., Herrero-Beaumont G., Kaklamanis P., Lohmander S., Maheu E., Martín-Mola E., Pavelka K., Punzi L., Reiter S., Sautner J., Smolen J., Verbruggen G., and Zimmermann-Górska I. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66 (2007) 377-388
4. Kienzler J, Gold M, Nollevaux F. Systemic bioavailability of topical diclofenac sodium gel 1% versus oral diclofenac sodium in healthy volunteers. J Clin Pharmacol New Drugs. In press.